within Pharmacolibrary.Drugs.ATC.D;

model D09AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.91,
    Cl             = 0.36 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0125,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0033333333333333335,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Fusidic acid is a steroidal antibiotic, primarily used for the treatment of infections caused by Staphylococcus species, including methicillin-resistant Staphylococcus aureus (MRSA). It is used both topically and systemically. Its main application is in skin infections, conjunctivitis, and occasionally for more severe systemic staphylococcal infections in combination with other antibacterials. Fusidic acid is approved and in use today in many countries, though its use for systemic infections is more restricted.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after a single 500 mg oral dose in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Turnidge, J (1999). Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. <i>International journal of antimicrobial agents</i> 12 Suppl 2 S23–S34. DOI:<a href=&quot;https://doi.org/10.1016/s0924-8579(98)00071-5&quot;>10.1016/s0924-8579(98)00071-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10528784/&quot;>https://pubmed.ncbi.nlm.nih.gov/10528784</a></p></li><li><p>Reeves, DS (1987). The pharmacokinetics of fusidic acid. <i>The Journal of antimicrobial chemotherapy</i> 20(4) 467–476. DOI:<a href=&quot;https://doi.org/10.1093/jac/20.4.467&quot;>10.1093/jac/20.4.467</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3316149/&quot;>https://pubmed.ncbi.nlm.nih.gov/3316149</a></p></li><li><p>Rowe, L, et al., &amp; Miller, TE (1992). An experimental evaluation of the pharmacokinetics of fusidic acid in peritoneal dialysis. <i>Journal of medical microbiology</i> 36(2) 71–77. DOI:<a href=&quot;https://doi.org/10.1099/00222615-36-2-71&quot;>10.1099/00222615-36-2-71</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1740786/&quot;>https://pubmed.ncbi.nlm.nih.gov/1740786</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D09AA02;
